149 related articles for article (PubMed ID: 35736358)
21. Subsequent primary cancers after basal-cell carcinoma: A nationwide study in Finland from 1953 to 1995.
Milán T; Pukkala E; Verkasalo PK; Kaprio J; Jansén CT; Koskenvuo M; Teppo L
Int J Cancer; 2000 Jul; 87(2):283-8. PubMed ID: 10861488
[TBL] [Abstract][Full Text] [Related]
22. Cutaneous malignancies: BCC, SCC, and MM.
Vargo N
Dermatol Nurs; 2006 Apr; 18(2):183, 200. PubMed ID: 16708685
[No Abstract] [Full Text] [Related]
23. Management of non-melanoma skin cancer.
Lazareth V
Semin Oncol Nurs; 2013 Aug; 29(3):182-94. PubMed ID: 23958216
[TBL] [Abstract][Full Text] [Related]
24. Basal cell carcinoma of the scalp resulting in spine metastasis in a black patient.
Oram Y; Orengo I; Alford E; Green LK; Rosen T; Netscher DT
J Am Acad Dermatol; 1994 Nov; 31(5 Pt 2):916-20. PubMed ID: 7962748
[TBL] [Abstract][Full Text] [Related]
25. [Basal cell carcinomas].
Renaud-Vilmer C; Basset-Seguin N
Rev Prat; 2014 Jan; 64(1):37-44. PubMed ID: 24649544
[TBL] [Abstract][Full Text] [Related]
26. Incidence of Basal Cell Carcinoma and Squamous Cell Carcinoma in Patients on Antiprogrammed Cell Death-1 Therapy for Metastatic Melanoma.
Zhao CY; Hwang SJE; Anforth R; Carlos G; Chou S; Carlino M; Fernández-Peñas P
J Immunother; 2018 Sep; 41(7):343-349. PubMed ID: 29939876
[TBL] [Abstract][Full Text] [Related]
27. Predicting the Risk of a Second Basal Cell Carcinoma.
Verkouteren JAC; Smedinga H; Steyerberg EW; Hofman A; Nijsten T
J Invest Dermatol; 2015 Nov; 135(11):2649-2656. PubMed ID: 26121210
[TBL] [Abstract][Full Text] [Related]
28. Basal cell carcinoma-treatments for the commonest skin cancer.
Berking C; Hauschild A; Kölbl O; Mast G; Gutzmer R
Dtsch Arztebl Int; 2014 May; 111(22):389-95. PubMed ID: 24980564
[TBL] [Abstract][Full Text] [Related]
29. Pediatric basal cell carcinoma: case reports and literature review.
Efron PA; Chen MK; Glavin FL; Kays DW; Beierle EA
J Pediatr Surg; 2008 Dec; 43(12):2277-80. PubMed ID: 19040953
[TBL] [Abstract][Full Text] [Related]
30. Genome-wide association studies and polygenic risk scores for skin cancer: clinically useful yet?
Roberts MR; Asgari MM; Toland AE
Br J Dermatol; 2019 Dec; 181(6):1146-1155. PubMed ID: 30908599
[TBL] [Abstract][Full Text] [Related]
31. Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines.
Peris K; Fargnoli MC; Garbe C; Kaufmann R; Bastholt L; Seguin NB; Bataille V; Marmol VD; Dummer R; Harwood CA; Hauschild A; Höller C; Haedersdal M; Malvehy J; Middleton MR; Morton CA; Nagore E; Stratigos AJ; Szeimies RM; Tagliaferri L; Trakatelli M; Zalaudek I; Eggermont A; Grob JJ;
Eur J Cancer; 2019 Sep; 118():10-34. PubMed ID: 31288208
[TBL] [Abstract][Full Text] [Related]
32. Parkinson's Disease, Melanoma, and Keratinocyte Carcinoma: A Population-Based Study.
Lerman S; Amichai B; Weinstein G; Shalev V; Chodick G
Neuroepidemiology; 2018; 50(3-4):168-173. PubMed ID: 29566384
[TBL] [Abstract][Full Text] [Related]
33. Dermoscopy in the diagnosis and management of basal cell carcinoma.
Lallas A; Apalla Z; Ioannides D; Argenziano G; Castagnetti F; Moscarella E; Longo C; Palmieri T; Ramundo D; Zalaudek I
Future Oncol; 2015 Nov; 11(22):2975-84. PubMed ID: 26450622
[TBL] [Abstract][Full Text] [Related]
34. Association of Shiny White Blotches and Strands With Nonpigmented Basal Cell Carcinoma: Evaluation of an Additional Dermoscopic Diagnostic Criterion.
Navarrete-Dechent C; Bajaj S; Marchetti MA; Rabinovitz H; Dusza SW; Marghoob AA
JAMA Dermatol; 2016 May; 152(5):546-52. PubMed ID: 26792406
[TBL] [Abstract][Full Text] [Related]
35. Is early detection of basal cell carcinoma worthwhile? Systematic review based on the WHO criteria for screening.
Hoorens I; Vossaert K; Ongenae K; Brochez L
Br J Dermatol; 2016 Jun; 174(6):1258-65. PubMed ID: 26872563
[TBL] [Abstract][Full Text] [Related]
36. Increase in basal cell carcinoma incidence steepest in individuals with high socioeconomic status: results of a cancer registry study in The Netherlands.
van Hattem S; Aarts MJ; Louwman WJ; Neumann HA; Coebergh JW; Looman CW; Nijsten T; de Vries E
Br J Dermatol; 2009 Oct; 161(4):840-5. PubMed ID: 19438849
[TBL] [Abstract][Full Text] [Related]
37. Epidemiological and pathological aspects of skin cancer in North East of Romania.
Andrese E; Solovăstru LG; Taranu T; Iancu LS
Rev Med Chir Soc Med Nat Iasi; 2014; 118(2):457-62. PubMed ID: 25076715
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of prospectively collected presenting signs/symptoms of biopsy-proven melanoma, basal cell carcinoma, squamous cell carcinoma, and seborrheic keratosis in an elderly male population.
Askari SK; Schram SE; Wenner RA; Bowers S; Liu A; Bangerter AK; Warshaw EM
J Am Acad Dermatol; 2007 May; 56(5):739-47. PubMed ID: 17258839
[TBL] [Abstract][Full Text] [Related]
39. Comparative aspects of melanoma and non-melanoma skin cancers in Japan.
Ikeda S; Kiyohara Y; Mizutani H
J Invest Dermatol; 1989 May; 92(5 Suppl):204S-209S. PubMed ID: 2715651
[TBL] [Abstract][Full Text] [Related]
40. Malignant melanoma and nonmelanoma skin cancers in Northrhine-Westphalia, Germany: a patient- vs. diagnosis-based incidence approach.
Stang A; Ziegler S; Büchner U; Ziegler B; Jöckel KH; Ziegler V
Int J Dermatol; 2007 Jun; 46(6):564-70. PubMed ID: 17550552
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
